Global Anticoagulants Market Poised for Growth, Expected to Reach $66.32 Billion by 2027

LANDON, GREATER LANDON, UK, November 16, 2023 /EINPresswire.com/ -- The global anticoagulants market is anticipated to experience significant expansion, ascending from $40.63 billion in 2022 to $44.81 billion in 2023, demonstrating a robust compound annual growth rate (CAGR) of 10.3%. Despite challenges posed by the ongoing Russia-Ukraine war, impeding global economic recovery from the COVID-19 pandemic, the market is projected to expand to $66.32 billion by 2027, driven by the escalating prevalence of cardiovascular diseases worldwide.

Increasing Cardiovascular Diseases Drive Market Growth

The escalating incidence of cardiovascular diseases (CVDs) serves as a pivotal driver propelling the growth of the anticoagulants market in the forthcoming years. CVDs, encompassing a spectrum of heart and blood vessel disorders, represent a leading cause of mortality globally, with a significant impact on low- and middle-income nations. Pharmacotherapeutic interventions such as direct oral anticoagulants play a crucial role in mitigating thrombosis in various cardiovascular conditions. According to the World Health Organization's report in 2021, approximately 17.9 million individuals worldwide succumbed to cardiovascular diseases, constituting 32% of all global deaths, with heart attacks and strokes accounting for 85% of these fatalities. Thus, the escalating burden of cardiovascular diseases fuels the growth of the anticoagulants market.

Explore the global anticoagulants market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp

Key Players and Market Trends

Key players in the anticoagulants market include GlaxoSmithKline plc., Pfizer Inc., Sanofi, and Bayer AG, among others, contributing significantly to the industry's competitive landscape. Ongoing clinical trials investigating anticoagulant treatments for COVID-19 represent a notable trend shaping the market, with institutions such as the National Institutes of Health (NIH) in the USA initiating Phase III clinical trials to assess the efficacy of blood thinners in preventing life-threatening blood clots in COVID-19 patients. These clinical trials underscore the industry's concerted efforts to address the thrombotic complications associated with the viral infection.

Segments:

• By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
• By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
• By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
• By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
• By End User: Hospitals, Homecare, Specialty Centers, Other End-Users

Geographical Insights: North America Leading, Growth Prospects in Asia-Pacific

North America emerged as the largest region in the anticoagulants market in 2022, while Asia-Pacific is poised to witness substantial growth in the forecast period. The comprehensive report provides detailed insights into regional dynamics, market trends, and potential growth opportunities.

Access the complete report for an in-depth analysis of the global anticoagulants market:
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

Anticoagulants Global Market Report 2023 from TBRC covers the following information:

1. Market size date for the forecast period: Historical and Future
2. Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
3. Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Anticoagulants Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on anticoagulants market size, anticoagulants market drivers and trends, anticoagulants market major players, competitors' revenues, market positioning, and anticoagulants market growth across geographies. The anticoagulants market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Blood Culture Tests Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

Blood Transfusion Diagnostics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Patient Blood Management Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn